David Chang, AAO 2018 – Updated guidelines for cleaning ophthalmic tools (part 2 of 2)
In this second part of his interview, Professor David F Chang discusses his recent study which was presented at AAO 2018 – “Endophthalmitis Reduction with Intracameral Moxifloxacin After Posterior Capsule Rupture”. This 6-year retrospective study involving more than 1,540,000 consecutive cases of cataract surgery, half of which had intracameral moxifloxacin, which lowered the infection rate from 7/10,000 to 2/10,000. They also investigated the effect of posterior capsule rupture with and without intracameral moxifloxacin and found that the use of intracameral antibiotic was very effective. He then touches on the effect of climate change regulations on the updated guidelines for the cleaning, sterilization and reuse of ophthalmic tools.
1. Tell us about your recent study: “Endophthalmitis Reduction with Intracameral Moxifloxacin After Posterior Capsule Rupture” (0:11)
2. Using fewer resources is of increasing concern in the light of evidence of climate change. How is this addressed in the new guidelines? (2:10)
Speaker disclosures: David Chang has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Refractive Surgery
Mitchell A Jackson, Hawaiian Eye and Retina 2023: Intraocular lens exchange – surgical pearls
It was a pleasure to have the opportunity to meet with Dr Mitchell A Jackson (Jacksoneye, Lake Villa, IL, USA) who shared surgical pearls from his presentation, on successful IOL exchange with an open capsule. Questions: What risks are associated with intraocular lens (IOL) exchange with an open capsule? (0:19) What […]
Mitchell A Jackson, Hawaiian Eye and Retina 2023: Challenges for ophthalmic surgeons
We were delighted to speak with Dr Mitchell A Jackson (Jacksoneye, Lake Villa, IL, USA) on his views about the main challenges faced by ophthalmic surgeons today, and common reasons for IOL exchange. Questions: 1. What are the biggest challenges facing ophthalmologic surgeons today? (0:19) 2. What are the most common reasons for intraocular lens […]
Pilocarpine hydrochloride ophthalmic solution 1.25%: An innovative prescription eye drop for the treatment of presbyopia
Video abstract delivered by Dr Selina McGee (BeSpoke Vision, Edmond, OK, USA) for the article: McGee S, Waring GO, Pilocarpine hydrochloride ophthalmic solution 1.25%: an innovative prescription eye drop for the treatment of presbyopia. touchREVIEWS in Ophthalmology. 2022;16(2):54–62 DOI: https://doi.org/10.17925
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!